2003/2004 Publications Page |
Abu-Baker A, Messaed C, Laganiere J, Gaspar C, Brais B, Rouleau GA:
Involvement of the ubiquitin-proteasome pathway and
molecular chaperones in oculopharyngeal muscular
dystrophy (OPMD). Hum Mol Genet 12:2609-23, 2003.
Al Moustafa
AE, Foulkes WD, Benlimame N, Wong A, Yen L, Bergeron J, Batist
G, Alpert L, Alaoui-Jamali MA: E6/E7 proteins of HPV
type 16 and ErbB-2 cooperate to induce neoplastic
transformation of primary normal oral epithelial cells. Oncogene
23:350-8, 2004.
Al Moustafa
AE, Foulkes WD, Wong A, Jallal H, Batist G, Yu Q, Herlyn M, Sicinski P, Alaoui-Jamali MA: Cyclin D1 is essential for neoplastic
transformation induced by both E6/E7 and E6/E7/ErbB-2 cooperation in normal
cells. Oncogene 23:5252-6, 2004.
Almqvist EW, Brinkman RR, Wiggins S, Hayden MR, and The Canadian Collaborative Study of
Predictive Testing: Psychological consequences and predictors of adverse
events in the first 5 years after predictive testing for Huntington’s
disease. Clin Genet 64:300-309, 2003.
Askew DJ, Askew YS, Kato Y, Turner RF, Dewar K, Lehoczky
J,
Battersby BJ, Loredo-Osti JC*,
and Shoubridge EA: Nuclear genetic control of
mitochondrial DNA segregation. Nat Genet
33:183-186, 2003 (*co-authored by a postdoctoral fellow)
Bethin KE, Nagai Y, Sladek R,
Asada M, Sadovsky Y, Hudson TJ & Muglia LJ: Microarray analysis of uterine gene expression in mouse and
human pregnancy. Molecular Endocrinology
17:1454-1469, 2003.
Bouchard
L, Blancquaert I, Eisinger
F, Foulkes WD, Evans G, Sobol
H, Julian-Reynier C: Prevention and genetic testing
for breast cancer: variations in medical decisions. Soc Sci Med
58:1085-96, 2004.
Bradley J, Baltus A, Skaletsky H, Royce-Tolland M, Dewar K and
Brooks-Wilson AR, Kaurah P, Suriano G, Leach S, Senz J, Grehan N, Butterfield YS,
Jeyes J, Schinas J, Bacani J, Kelsey M, Ferreira P, MacGillivray
B, MacLeod P, Micek M, Ford J, Foulkes W, Australie K, Greenberg C, LaPointe M, Gilpin C, Nikkel S,
Gilchrist D, Hughes R, Jackson CE, Monaghan KG, Oliveira MJ, Seruca R, Gallinger S, Caldas C, Huntsman D: Germline E-cadherin mutations in hereditary diffuse gastric cancer:
assessment of 42 new families and review of genetic screening criteria. J Med Genet
41:508-517, 2004.
Chan EM, Bulman DE,
Paterson AD, Turnbull J, Andermann E, Andermann F, Rouleau GA,
Delgado-Escueta AV, Scherer SW, Minassian
BA: Genetic
mapping of a new Lafora progressive myoclonus epilepsy locus (EPM2B) on 6p22. J
Med Genet 40:671-5, 2003.
Chan EM, Young EJ, Ianzano
L, Munteanu I, Zhao X, Christopoulos
CC, Avanzini G, Elia M, Ackerley CA, Jovic NJ, Bohlega S, Andermann E, Rouleau GA, Delgado-Escueta
AV, Minassian BA, Scherer SW: Mutations in NHLRC1 cause
progressive myoclonus epilepsy. Nat
Genet 35:125-7, 2003 Oct.
Chiu C, Dewar
K, Wagner GP, Takahashi K, Ruddle F, Ledje C, Bartsch P, Scemana J-L, Stellwag E, Fried C,
Prohaska SJ, Stadler PF and
Amemiya CT: Bichir HoxA Cluster Sequence Reveals Surprising Trends in
Ray-finned Fish Genomic Evolution. Genome
Research 14:11-17,
2004.
Cianflone K, Phelis S, Davignon J, Gilfix BM: ApoE phenotype influences plasma ASP in hyperapoB
subjects. Atherosclerosis.
170:285-291, 2003.
Cossette P, Loukas A, Lafreniere RG, Rochefort D, Harvey-Girard E, Ragsdale DS, Dunn RJ,
Desautels A, Turecki G, Montplaisir J, Brisebois K,
Devon R, Helm J, Rouleau
G, Leitner Y, Lerman-Sagie
T, Lev D, Hayden M: The first nonsense mutation in alsin
results in a homogeneous phenotype of infantile-onset ascending spastic paralysis
with bulbar involvement in two siblings. Clin
Genet 64:210-215, 2003.
Dupre N, Howard HC, Mathieu J, Karpati
G, Vanasse M, Bouchard JP, Carpenter S, Rouleau GA: Hereditary motor and
sensory neuropathy with agenesis of the corpus callosum.
Ann Neurol 54(1):9-18, 2003.
Dupre N, Verlaan DJ, Hand CK,
Laurent SB, Turecki G, Davenport WJ, Acciarri N, Dichgans J, Ohkuma A, Siegel AM, Rouleau
GA: Linkage to the CCM2 locus and genetic heterogeneity in familial
cerebral cavernous malformation. Can
J Neurol Sci
(30)122-128, 2003.
Edwards
S, Meitz J, Eles R, Evans
C, Easton D, Hopper J, Giles G, Foulkes WD, Narod S, Simard J, Badzioch M, Mahle L:
International ACTANE Consortium. Results of a genome-wide linkage analysis in prostate
cancer families ascertained through the ACTANE consortium. Prostate
57:270-279, 2003.
El-Maarri O, Seoud M, Coullin P, Herbiniaux U, Oldenburg J, Rouleau
G, Slim R: Maternal alleles acquiring paternal methylation
patterns in biparental complete hydatidiform
moles. Hum Mol Genet 12:1405-13, 2003.
Elstein E, Elstein J: Hypertensive response to exercise may predict
abnormalities on ambulatory blood pressure monitoring. Clin
Invest Med 26:93, 2003.
Ernest S, Carter M, Hosack
A, Rosenblatt DS, Ross E, and Nadeau
JH: Nutrigenes, functional genomics and systems
biology. J Nutr
133: 4267-4268, 2003.
Fan X, Messaed C, Dion P, Laganiere J, Brais B, Karpati G,
Fan X,
Farhadi HF, Lepage
P, Forghani R, Friedman HC, Orfali
W, Jasmin L, Miller W, Hudson TJ, Peterson AC: A combinatorial network of evolutionarily
conserved myelin basic protein regulatory sequences confers distinct glial-specific phenotypes. J. of Neuroscience 23:10214–10223, 2003.
Florez JC, Burtt N, de Bakker PIW, Almgren P, Tuomi T, Holmkvist J, Gaudet D, Hudson TJ,
Schaffner SF, Daly MJ, Hirschhorn
JN, Groop L and Altshuler
D: Haplotype structures and genotype-phenotype
correlations of the sulfonylurea receptor (SUR1) and the islet ATP-sensitive
potassium channel (Kir6.1) gene region. Diabetes. 53:1360-1368,
2004.
Foulkes WD, Brunet JS, Stefansson IM, Straume O, Chappuis PO, Begin LR, Hamel N, Goffin
JR, Wong N, Trudel M, Kapusta
L, Porter P, Akslen LA: The Prognostic Implication of
the Basal-Like (Cyclin
high/p27low/p53+/Glomeruloid-Microvascular-Proliferation+) Phenotype of
BRCA1-Related Breast Cancer. Cancer Res
64:830-835, 2004.
Foulkes WD, Metcalfe K, Hanna W, Lynch HT, Ghadirian P, Tung N, Olopade O, Weber B,
McLennan J,
Foulkes WD, Metcalfe K, Sun P, Hanna
WM, Lynch HT, Ghadirian P, Tung
N, Olopade OI, Weber BL, McLennan J, Olivotto IA, Begin LR, Narod SA:
Estrogen receptor status in BRCA1- and BRCA2-related breast cancer: the
influence of age, grade, and histological type. Clin
Cancer Res 10:2029-34, 2004.
Foulkes WD, Stefansson IM, Chappuis
PO, Bégin LR, Goffin JR, Wong N, Trudel M and Akslen
LA: Germ-line BRCA1 mutations and the basal epithelial
phenotype of breast cancer. J Natl Cancer Inst 95:1482-5, 2003.
Gagnon F, Bull SB, Morgan K, Rannala B, and Rousseau F:
Genetic epidemiologic research using the Canadian National Birth Cohort platform:
initiating the discussion. 2003.
Gauthier J, Joober R, Mottron L, Laurent S, Fuchs M, De Kimpe
V,
Ghadirian
P, Lubinski J, Lynch H, Neuhausen
SL, Weber B, Isaacs C, Baruch RG, Randall S, Ainsworth P, Freidman E, Horsman D, Tonin P,
Foulkes WD, Tung
N, Sun P, Narod SA: Smoking and the risk of breast
cancer among carriers of BRCA mutations. Int
J Cancer 110:413-6, 2004.
Gilfix BM: Hyperhomocysteinemia: genetic determinants and selected
mouse models. Clin Invest Med 26:121-132, 2003.
Goffin JR, Chappuis PO, Bégin LR, Wong N,
Brunet JS, Hamel N, Paradis AJ, Boyd J, Foulkes WD: Impact of germ-line BRCA1
mutations and over-expression of p53 on prognosis and response to treatment
following breast carcinoma. Cancer 97:527-36, 2003.
Goffin JR, Straume O, Chappuis PO, Brunet
J-S, Bégin LR, Hamel N, Wong N, Akslen
LA and Foulkes WD: Glomeruloid microvascular
proliferation is associated with p53 expression, germline
BRCA1 mutations and an adverse outcome following breast cancer. Br J Cancer 89:1031-4, 2003.
Gros-Louis F, Laurent S, Lopes AA, Khoris
J, Meininger V, Camu W, Rouleau GA: Absence of mutations in the hypoxia response element
of VEGF in ALS. Muscle Nerve
28:774-5, 2003.
Gros-Louis F,
Guillem JG, Rapaport BS, Kirchhoff T, Kolachana P, Nafa K, Glogowski E, Finch R, Huang H, Foulkes
WD, Markowitz A, Ellis NA, Offit
K: A636P is associated with early-onset colon cancer in Ashkenazi Jews. J Am
Coll Surg 196:222-5,
2003.
Halford SE, Sawyer EJ, Lambros MB, Gorman P, Macdonald ND, Talbot IC, Foulkes WD,
Gillett CE, Barnes DM, Akslen LA, Lee K, Jacobs IJ, Hanby AM, Ganesan TS, Salvesen HB, Bodmer WF, Tomlinson
IP, Roylance RR: MSI-low, a real phenomenon which
varies in frequency among cancer types. J Pathol
201:389-394, 2003.
Hamel N, Kotar K, Foulkes WD: Founder mutations in BRCA1/2 are not frequent in
Canadian Ashkenazi Jewish men with prostate cancer. BMC Med Genet 4:7,
2003.
Hand CK, Devon RS, Gros-Louis
F, Rochefort D, Khoris J, Meininger V, Bouchard JP, Camu W,
Hayden MR,
Harding CO, Pillers DA,
Steiner RD, Bottiglieri T, Rosenblatt DS, Debley J, and Gibson KM:
Potential for misdiagnosis due to lack of
combined methylmalonic aciduria/hyperhomocysteinemia
(cblC) in the neonate. J Perinatal 23:384-386, 2003.
Hashibe M, Brennan P, Strange
RC, Bhisey R, Cascorbi I,
Lazarus P, Oude Ophuis MB, Benhamou S, Foulkes WD, Katoh T, Coutelle C, Romkes M, Gaspari L, Taioli E and Boffeta P: Meta and
pooled analyses of GSTM1, GSTT1,GSTP1, CYP1A1 genotypes and the risk of head
and neck cancer. Cancer
Epidemiol Biomarker Prev 12:1509-17,
2003.
Hilton JF, Christensen KE, Watkins D, Raby BA, Renaud Y, de la Luna S, Estivill X, MacKenzie RE, Hudson TJ, Rosenblatt DS: The molecular basis of glutamate formiminotransferase
deficiency. Hum Mutations.
22:67-73, 2003.
Howard HC, Dupre N, Mathieu J, Bouchard JP, Rouleau GA: Severe neuropathy with agenesis of the corpus callosum. Medicine Sciences 19:414-6, 2003.
International HapMap
Consortium, (Hudson TJ, co-author
among 173, is leader of the Canadian group and member of the Methods group): The
International HapMap Project. Nature 426:789-796, 2003.
Kaplan F,
Comber J, Sladek R, Hudson TJ, Muglia LJ, Macrae T, Gagnon S,
Asada M, Brewer JA, &
Karakiewicz PI, Foulkes W,
Tanguay S, Elhilali MM, Aprikian AG: Familial prostate and breast cancer in men
treated with prostatectomy for prostate cancer: a population based case-control
study. J Urol 169:240-4, 2003.
Koenekoop RK, Loyer M, Hand CK, Al Mahdi H, Dembinska O, Beneish R, Racine J, Rouleau
GA: Novel
RPGR mutations with distinct retinitis pigmentosa
phenotypes in French-Canadian families. Am J Ophthalmol 136:678-87, 2003.
Kotar K, Hamel N, Thiffault I, Foulkes WD: The RNASEL 471delAAAG allele and
prostate cancer in Ashkenazi Jewish men. J Med Genet 40:e22, 2003.
Laurans MS, DiLuna ML, Shin D, Niazi F, Voorhees JR, Nelson-Williams C, Johnson EW, Siegel
AM, Steinberg GK, Berg MJ, Scott RM, Tedeschi G, Enevoldson TP, Anson J, Rouleau
GA, Ogilvy C, Awad IA, Lifton
RP, Gunel M: Mutational analysis of 206
families with cavernous malformations. J
Neurosurg 99:38-43, 2003.
Lavoie H, Debeane F, Trinh
QD, Turcotte JF, Corbeil-Girard
LP, Dicaire MJ, Saint-Denis A, Page M, Rouleau GA, Brais
B: Polymorphism,
shared functions and convergent evolution of genes with sequences coding for polyalanine domains.
Hum Mol Genet 12:2967-79, 2003.
Leveque G, Forgetta V, Morroll S, Smith AL, Bumstead N,
Barrow P, Loredo-Osti JC, Morgan K, and Malo D: Allelic variation
in TLR4 is linked to susceptibility
to Salmonella enterica
serovar Typhimurium
infection in chickens. Infection and
Immunity 71:1116-1124, 2003.
Liquori CL, Berg MJ, Siegel AM, Huang E, Zawistowski
JS, Stoffer T, Verlaan D, Balogun F, Hughes L, Leedom TP,
Plummer NW, Cannella M, Maglione
V, Squitieri F, Johnson EW, Rouleau
GA, Ptacek L, Marchuk
DA: Mutations
in a gene encoding a novel protein containing a phosphotyrosine-binding
domain cause type 2 cerebral cavernous malformations. Am
J Hum Genet 73:1459-64, 2003.
Lowry RB, Innes AM, Bernier
FP, McLeod DR, Greenberg CR, Chudley AE, Chodirker B, Marles SL, Crumley MJ, Loredo-Osti JC, Morgan K, Fujiwara MJ: Bowen-Conradi syndrome: a
clinical and genetic study. Am J Med
Genet 120A:423-428, 2003.
Matakidou A, Hamel N, Polpat S, Henderson K, Kantemiroff
T, Harmer C, Clarke SE, Houlston RS, Foulkes WD: Risk
of non-medullary thryoid
cancer influenced by polymorphic
variation in the thyroglobulin gene. Carcinogenesis,
2003.
Metcalfe
K, Lynch HT, Ghadirian P, Tung
N, Olivotto I, Warner E, Olopade
OI, Eisen A, Weber B, McLennan J, Sun P, Foulkes WD, Narod
SA: Contralateral breast cancer in BRCA1 and BRCA2
mutation carriers. J Clin Oncol
22:2328-35, 2004.
Mira MT, Alcaïs A, Thuc NV, Moraes MO, Di Flumeri C, Thai VH, Phuong MC,
Huong NT, Ngoc Ba N, Sarno EN, Alter A, Montpetit A, Moraes ME, Moraes JR, Doré C, Gallant CJ, Lepage P, Verner A, Van de Vosse E, Hudson TJ, Abel L, Schurr
E: The 5-prime regulatory region shared by the PARK2 and PACRG genes is
associated with susceptibility to leprosy. Nature 427:636-640, Feb. 2004.
Mootha VK, Lepage P,
Miller K, Bunkenborg J, Reich M, Hjerrild
M, Delmonte T, Villeneuve
A, Sladek R, Zhu F-H, Mitchell GA, Morin C, Mann M, Hudson TJ, Robinson B, Rioux JD & Lander ES: Identification of a gene causing
human cytochrome c oxidase
deficiency by integrative genomics. Proc
Natl Acad Sci U S A. 100:605-10, Jan. 2003.
Mullick A, Elias M, Harakidas P, Marcil A, Whiteway M, Ge B, Hudson TJ,
Caron AW, Bourget L, Picard
S, Jovcevski O, Massie B, Thomas DY: Gene expression
in HL60 granulocytoids and human polymorphonuclear
leukocytes exposed to candida albicans
dagger. Infect Immun 72:414-429, 2004.
Namour F, Helfer A-C, Quadros EV, Alberto J-M, Bibi H, Orning L, Rosenblatt
DS, and Guéant J-L: Transcobalamin
deficiency due to activation of an intra exonic
cryptic splice site. Br J Haematol 123:915-920, 2003.
Pastinen T, Sladek R, Gurd S, Sammak A, Ge B, Lepage P, Lavergne K, Villeneuve A, Gaudin T, Brandstrom H, Beck A, Verner A, Kingsley J, Harmsen E, Labuda D, Morgan K, Vohl M-C, Naumova AK, Sinnett D, Hudson TJ: A survey of genetic and epigenetic variation affecting human gene expression. Physiol Genomics 16:184-193, 2003.
Presneau N, Manderson EN, and Tonin PN: The quest for tumor suppressor
gene phenotype. Curr Molec. Med. 3:605-629, 2003.
Presneau N, Mes-Masson A-M, Ge B, Provencher D, Hudson
TJ, Tonin PN:
Patterns of expression of chromosome 17 genes in primary cultures of
normal ovarian surface epithelia and epithelial ovarian cancer cell lines. Oncogene (Oncogenomics) 22:1568-79, 2003.
Presneau N, Mes-Masson A-M, Novak J, Lee PD, Provencher
D, Hudson TJ, Tonin
PN. Differential expression of 304 ESTs located on
chromosome 17 in human epithelial ovarian cancer cell lines using DNA microarrays. Oncogene 22:1568-79, 2003.
Robson
ME, Chappuis PO, Satagopan
J, Wong N, Boyd J, Goffin JR, Hudis C, Roberge D, Norton L,
Begin LR, Offit K, Foulkes WD: A
combined analysis of outcome following breast cancer: differences in survival
based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment. Breast Cancer Res 6:R8-R17, 2004.
Segurado R, Detera-Wadleigh SD,
Levinson DF, Lewis CM, Gill M, Nurnberger JI Jr, Craddock N, DePaulo JR, Baron
M, Gershon ES, Ekholm J, Cichon S, Turecki G, Claes S, Kelsoe JR, Schofield PR,
Badenhop RF, Morissette J,
Coon H, Blackwood D, McInnes LA, Foroud
T, Edenberg HJ, Reich T, Rice JP, Goate
A, McInnis MG, McMahon FJ, Badner JA, Goldin LR, Bennett P, Willour VL,
Zandi PP, Liu J, Gilliam C, Juo
SH, Berrettini WH, Yoshikawa T, Peltonen
L, Lonnqvist J, Nothen MM,
Schumacher J, Windemuth C, Rietschel
M, Propping P, Maier W, Alda M, Grof
P, Rouleau GA, Del-Favero
J, Van Broeckhoven C, Mendlewicz
J, Adolfsson R, Spence MA, Luebbert
H, Adams LJ, Donald JA, Mitchell PB, Barden N, Shink E, Byerley W, Muir W, Visscher PM, Macgregor S, Gurling
H, Kalsi G, McQuillin A,
Escamilla MA, Reus VI, Leon P, Freimer
NB, Ewald H, Kruse TA, Mors
O, Radhakrishna U, Blouin
JL, Antonarakis SE, Akarsu
N: Genome scan meta-analysis of schizophrenia and bipolar disorder, part III:
Bipolar disorder. Am J Hum Genet 73:49-62, 2003.
Selzer RR, Rosenblatt
DS, Laxova R, Hogan, K: Adverse effect of nitrous
oxide in a child with 5,10-methylenetetrahydrofolate reductase
deficiency. N Engl
J Med.349:45-50, 2003.
Sequeira A, Kim C, Seguin M, Lesage A, Chawky N, Desautels A, Tousignant M, Vanier C, Lipp O, Benkelfat C, Rouleau G, Turecki G: Wolfram syndrome and suicide: Evidence for a role of WFS1 in suicidal and impulsive behavior. Am J Med Genet 119B:108-13, 2003.
Sibani S, Leclerc D, Weisberg IS, O’Ferrall E, Watkins
D, Artigas C, Rosenblatt DS, and Rozen R:
Characterization of mutations in severe methylenetetrahydrofolate
reductase deficiency reveals an FAD-responsive
mutation. Hum Mutation 21:509-520, 2003.
Sklar P,
Stojanovic N and Dewar K:
Identifying Multiple Alignment Regions Satisfying Simple Formulas and Patterns.
Bioinformatics, 2004 (PubMed electronic pre-issue available at:
http://bioinformatics.oupjournals.org/cgi/reprint/bth196v1.pdf).
Szijan I, Rochefort D, Bruder C, Surace E, Machiavelli
G, Dalamon V, Cotignola J, Ferreiro V, Campero A, Basso A, Dumanski JP, Rouleau GA:
NF2 tumor suppressor gene: a comprehensive and efficient detection of somatic
mutations by denaturing HPLC and microarray-CGH. Neuromol Med 3:41-52, 2003.
Thiffault
I, Hamel N, Pal T, McVety S, Marcus VA, Farber D, Cowie S, Deschenes J, Meschino W, Odefrey F, Goldgar D, Graham T, Narod S,
Watters AK, MacNamara E, Sart
DD, Chong G, Foulkes WD: Germline truncating mutations in both MSH2 and BRCA2 in a
single kindred. Br
J Cancer 90:483-491, 2004.
Toulouse A, Rochefort D, Roussel J, Joober R, Rouleau GA: Molecular cloning and
characterization of human RAI1, a gene associated with schizophrenia. Genomics
8:162-71, 2003.
Turecki G, Sequeira A, Gingras Y, Seguin M, Lesage A, Tousignant M, Chawky N, Vanier C,
Lipp O, Benkelfat C, Rouleau GA: Suicide and serotonin: Study of
variation at seven serotonin receptor genes in suicide completers. Am J Med
Genet 118B:36-40, 2003.
Yamamoto K, Cubells JF, Gelernter J, Benkelfat
C, Lalonde P, Bloom D, Lal
S, Labelle A, Turecki G, Rouleau
GA, Joober R: Dopamine Beta-Hydroxylase
(DBH) gene and schizophrenia phenotypic variability: A genetic association
study. Am J Med Genet 117B:33-8,
2003.
Carmel R,
Rosenblatt DS: Disorders of cobalamin and folate metabolism, in Blood, Principles and Practice of
Haematology (2nd ed), R.I. Handin, S.E.Lux, and T.P. Stossel, (eds). Lippincott Williams &
Wilkins. 2003, pp 1361-1397.
Rezvani I, and Rosenblatt
DS: An Approach to Inborn Errors of Metabolism, in Nelson Textbook of Pediatrics (17th ed), R.E. Behrman,
R.M. Kliegman and H.B. Jenson (eds.) W.B. Saunders
Company, Philadelphia, 2003, Chapter 74.3 pp 405-407; 74.6 pp 409-418.
Tonin PN. 2003. Evaluation and management of women with a strong family history of breast cancer. In ‘The Conservative Treatment of Early Breast Cancer’, G.C. Peltecu (Ed). 2003 pp 367-384. [published in Romanian ]
Caron J, Loredo-Osti
JC, Morgan K, Malo
D. Genetics of host resistance to chronic Salmonella
infection in mice. (Poster presentation at the 17th International
Mouse Genome Conference,
Dean NL,
Faith JM, Lemire
M, Verner A, Darmond-Zwaig
C, Platko J, Rioux J, Morgan K, Hudson TJ, Gaudet D, and Engert JC: A
genome-wide scan for NIDDM susceptibility in the Saguenay-Lac-Saint-Jean
region of
Frosk P, Greenberg CR, Poulin
A, Lamont R, Nylen E, Zalik
M, Straub V, Bushby K, Frappier D, Roslin NM, Morgan K,
Fujiwara TM, and Wrogemann
K: A common founder mutation in FKRP causes
limb girdle muscular dystrophy type 2I (LGMD2I) in both Hutterite
and European populations. Am J Hum Genet
73:388, 2003. Poster
Kasprzak L, Tremblay F, Galvez M, Halwani F, and Foulkes
WD: Invasive breast cancer following bilateral subcutaneous mastectomy in a
BRCA2 mutation carrier. Am J Hum Genet 73: Poster
presentation
Lamont RE, Nylen
EG, Mauthe J, Coghlan G,
Greenberg CR, Zelinski T, Wrogemann
K, Triggs-Raine B, Frappier
D,
Lemire, M.,
Lerner-Ellis
JP, Dobson CM, Wai T, Watkins D, Tirone JC, Dor
C, Lepage P, Gravel RA, Rosenblatt DS: Mutation and biochemical analysis of patients
belonging to the cblA
complementation class of vitamin B12-dependent methylmalonic
aciduria. Am J
Hum Genet 73:459 (1696), 2003.
Loredo-Osti, JC, Fujiwara
TM, and Morgan K: Altered
states: even clones are not created equal. Poster
Abstracts, p. 14, 2003. Poster
Roslin NR, Loredo-Osti JC, Morgan K, Tessier
J and Bonnardeaux A. Heritability of urine calcium in
French-Canadian families ascertained for kidney stones. Poster at Hôpital Maisonneuve-Rosemont 10e
Journée Annuelle de la Recherche,
Foulkes WD. BRCA1 functions as a breast stem cell
regulator. J Med
Genet 41:1-5, 2004.
Members | Report | Meetings
Publications | Funds | Financial
© 2005 Finestone Laboratory